Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.
- Status
- COMPLETED
- Phase
- N/A
Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS
- Status
- COMPLETED
- Phase
- PHASE1
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS
- Status
- WITHDRAWN
- Phase
- PHASE2
Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
- Status
- WITHDRAWN
- Phase
- N/A
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood Transplantation From Unrelated Donors
- Status
- RECRUITING
- Phase
- N/A
Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)
- Status
- TERMINATED
- Phase
- PHASE3
Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
- Status
- COMPLETED
- Phase
- PHASE1
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS
- Status
- COMPLETED
- Phase
- PHASE2